Germany· DE-A57-e4bacd291d009c38
Valsainda Apontis
A medicinal product containing valsartan, indapamide, registered in Germany by Krka, D.D., Novo Mesto.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Valsartan, Indapamide
- Manufacturer
- Krka, D.D., Novo Mesto
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Valsartan, indapamide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVABINXOKrka, d.d., Novo mesto, Novo mesto
- PolandVabinxoKrka, d.d., Novo mesto
- SpainVALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADAKrka D.D. Novo Mesto
- FinlandValomindoKRKA d.d. Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Valsartan/Indapamid Tad
- Bulgaria · Валоминдо, Валсартан/Индапамид Билев
- Cyprus · Valomindo
- Czechia · Vabinxo, Valsartan/Indapamid Krka
- Estonia · Vabinxo, Yndivan
- Spain · Valomindo
- Finland · Valomindo
- Greece · Valomindo
- Croatia · Valomindo
- Hungary · Norsiten, Vabincor
- Lithuania · Vabinxo
- Latvia · Vabinxo, Yndivan
- Poland · Vabinxo, Yndivan
- Portugal · Valomindo
- Romania · Valomindo, Yndivan
- Slovenia · Valomindo
- Slovakia · Vabinxo, Yndivan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47511361-f00c-4daa-be6a-7efa38c92c74 GET /v1/drugs/47511361-f00c-4daa-be6a-7efa38c92c74?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Valsartan, Indapamide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about valsartan, indapamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.